Addex Therapeutics Ltd
ADXN
$9.44
$0.525.83%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | -19.33% | 22.38% | -112.42% | 503.35% |
| Total Depreciation and Amortization | -- | -91.14% | -56.22% | -50.20% | 3,555.88% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | 20.67% | -25.04% | 107.39% | -4,058.21% |
| Change in Net Operating Assets | -- | -103.89% | 227.77% | 105.83% | -505.59% |
| Cash from Operations | -- | -2,385.07% | 94.18% | 84.89% | -21.48% |
| Capital Expenditure | -- | -- | 100.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -241.51% | -100.10% | -- |
| Cash from Investing | -- | -- | -166.18% | -100.13% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 0.00% | 18.18% | 26.67% | 95.50% |
| Issuance of Common Stock | -- | -81.25% | -27.27% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | 100.00% | -406.67% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 6,733.33% | -200.00% | 98.42% | -3,060.00% |
| Cash from Financing | -- | 5,550.00% | -233.33% | 99.06% | -133.74% |
| Foreign Exchange rate Adjustments | -- | -145.05% | 198.71% | -2,261.11% | -98.39% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | 196.68% |
| Net Change in Cash | -- | -6,656.47% | 98.32% | -121.23% | 193.33% |